|
|
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- Taking IMBRUVICA® | IMBRUVICA® (ibrutinib)
Find IMBRUVICA® (ibrutinib) dosing information and helpful tips for adding it to your routine and keeping track of treatments See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® Side Effects - CLL SLL | IMBRUVICA® (ibrutinib)
The most common side effects of IMBRUVICA® in adults with B-cell malignancies (CLL SLL and WM) include low platelet count; diarrhea; tiredness; muscle, bone, and joint pain; low white blood cell count; rash; low red blood cell count (anemia); bruising; and nausea
- How Does IMBRUVICA® (ibrutinib) Work?
Learn how IMBRUVICA® works for chronic lymphocytic leukemia treatment and small lymphocytic lymphoma See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® Side Effects Dosing - WM | IMBRUVICA® (ibrutinib)
View important information about IMBRUVICA® side effects, tips for side effects, and IMBRUVICA® dosage information for WM See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- CLL and SLL Treatment | IMBRUVICA® (ibrutinib)
Learn about treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) with IMBRUVICA® (ibrutinib) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® By Your Side | IMBRUVICA® (ibrutinib)
Learn about IMBRUVICA® (ibrutinib) By Your Side, a patient assistance program that provides financial options and support See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- WM Treatment | IMBRUVICA® (ibrutinib)
Find important information for patients about IMBRUVICA® (ibrutinib), a treatment for waldenström’s macroglobulinemia (WM) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® (ibrutinib) for WM
Learn about IMBRUVICA® (ibrutinib), a treatment for waldenström’s macroglobulinemia (WM) and potential side effects See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- Your Guide to Your IMBRUVICA (ibrutinib) Treatment Plan
IMBRUVICA® (ibrutinib) is a prescription medicine used to treat: • Adults with chronic lymphocytic leukemia (CLL) Small lymphocytic lymphoma (SLL) • Adults with chronic lymphocytic leukemia (CLL) Small lymphocytic lymphoma (SLL) with 17p deletion It is not known if IMBRUVICA® is safe and effective in children
|
|
英文每年常用名排名
2023 年排名
2022 年排名
2021 年排名
2020 年排名
2019 年排名
2018 年排名
2017 年排名
2016 年排名
2015 年排名
2014 年排名
2013 年排名
2012 年排名
2011 年排名
2010 年排名
2009 年排名
2008 年排名
2007 年排名
2006 年排名
2005 年排名
2004 年排名
2003 年排名
2002 年排名
2001 年排名
2000 年排名
英文名字起源
希伯来
希腊
条顿
印度
拉丁
拉丁语
古英语
英格兰
阿拉伯
法国
盖尔
英语
匈牙利
凯尔特
西班牙
居尔特
非洲
美洲土著
挪威
德国
威尔士
斯拉夫民族
古德语
爱尔兰
波斯
古法语
盎格鲁撒克逊
意大利
盖尔语
未知
夏威夷
中古英语
梵语
苏格兰
俄罗斯
土耳其
捷克
希腊;拉丁
斯干那维亚
瑞典
波兰
乌干达
拉丁;条顿
巴斯克语
亚拉姆
亚美尼亚
斯拉夫语
斯堪地纳维亚
越南
荷兰
|